Back to search

Article

Clinical Utility and Impact of the Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay on Treatment Decision: A Single-Center Retrospective Study

2022-01-31

Abstract excerpt

<h4>Background: </h4> Metagenomic next-generation sequencing (mNGS) of microbial cell-free DNA (mcfDNA) allows for non-invasive pathogen detection from plasma. However, there is little data describing the optimal role for this assay in real-world clinical decision making. Methods We performed a single-center retrospective cohort study of adult patients for whom a mcfDNA test was sent between May 2019 and February...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4a00efbc-54ba-5855-8e7d-60f2dbcae1d6
DOI
10.21203/rs.3.rs-1160543/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Utility and Impact of the Metagenomic Microbial Plasma Cell-Free DNA Next-Generation Sequencing Assay on Treatment Decision: A Single-Center Retrospective StudyDOI 10.21203/rs.3.rs-1160543/v1
Select a neighboring publication to make it the new centre.